Tag: CSE:NSHS

May 29, 2019

Colorado Passes Law Allowing Doctors to Prescribe Cannabis in Place of Opioids

NanoSphere Health Sciences (CSE:NSHS) (OTC: NSHSF) CEO Robert Sutton today congratulated the Governor and Legislature of Colorado for their passage...
May 2, 2019

NanoSphere Health Sciences and Stat Shield Technology Form Strategic Partnership to Launch Evolve Products for Veterans

NanoSphere Health Sciences (CSE:NSHS) (OTC:NSHSF), the biotechnology company behind the patented NanoSphere Delivery System™, is pleased to announce that it...
April 30, 2019

NanoSphere and Vertical Unveil the Future of Cannabis at Hall of Flowers Trade Show

NanoSphere Health Sciences (CSE:NSHS) (OTC: NSHSF) (‘NanoSphere or ‘the Company’) parent company of cannabis brand Evolve Formulas, in partnership with Vertical™,...
April 24, 2019

NanoSphere Health Sciences Has Received Notice of Allowance for a Patent for its Breakthrough Nanoparticle Encapsulations of NSAIDs

NanoSphere Health Sciences (CSE:NSHS) (OTC: NSHSF) has received formal Notice of Allowance from the Canadian Intellectual Property Office (CIPO) for...
April 2, 2019

NanoSphere Products Approved for Sale in California Cannabis Market

NanoSphere Health Sciences (CSE:NSHS)(OTC: NSHSF) is pleased to announce its Evolve cannabis products will be available for purchase in California...
March 7, 2019

NanoSphere Developing Production Lab at Delta 9 Cannabis

NanoSphere Health Sciences (CSE:NSHS) (OTC:NSHSF) (“NanoSphere” or the Company) is pleased to announce work has begun on the production facility...
February 21, 2019

NanoSphere Closes $2 Million Private Placement Offering

NanoSphere Health Sciences Inc. (CSE:NSHS) (OTC:NSHSF) (“Nanosphere” or “the Company”) is pleased to announce that it has closed its second and...